New data published in Hepatology showed that nonselective beta-blockers did not increase all-cause or cirrhosis-related mortality in patients with advanced cirrhosis and ascites. “In 2010 ...

particularly those with Child C cirrhosis.” Years ago, it was thought the “window of benefit” from nonselective beta-blockers (and carvedilol) closes as the degree of cirrhotic ...

Beta blockers are not effective in preventing development of varices—veins in the esophagus that can rupture and bleed—as a consequence of cirrhosis, according to a recent study by Yale School of ...

We use portal pressure measurements to ensure that our patients with liver cirrhosis receive both best diagnosis and effective beta-blocker therapy." The recently published study shows for the ...

Anti-inflammatory effects of beta-blockers in cirrhosis The recently published study shows for the first time that beta-blockers also have an impact on systemic inflammation. For this study ...

AMSTERDAM, the Netherlands — Nonselective beta-blocker therapy improves gastrointestinal permeability and decreases intestinal bacterial translocation in patients with cirrhosis and esophageal ...

‘Cirrhotic patients achieved a relevant reduction in inflammatory markers by taking beta-blocker therapy. It also decreased the chance of developing portal hypertension.’ In Austria, cirrhosis ...